vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and PEDEVCO CORP (PED). Click either name above to swap in a different company.

HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $23.1M, roughly 1.7× PEDEVCO CORP). HARTE HANKS INC runs the higher net margin — 5.5% vs -36.8%, a 42.4% gap on every dollar of revenue. On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs -15.4%). Over the past eight quarters, PEDEVCO CORP's revenue compounded faster (68.6% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

HHS vs PED — Head-to-Head

Bigger by revenue
HHS
HHS
1.7× larger
HHS
$39.9M
$23.1M
PED
Growing faster (revenue YoY)
PED
PED
+133.7% gap
PED
118.2%
-15.4%
HHS
Higher net margin
HHS
HHS
42.4% more per $
HHS
5.5%
-36.8%
PED
Faster 2-yr revenue CAGR
PED
PED
Annualised
PED
68.6%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HHS
HHS
PED
PED
Revenue
$39.9M
$23.1M
Net Profit
$2.2M
$-8.5M
Gross Margin
Operating Margin
-0.3%
-21.3%
Net Margin
5.5%
-36.8%
Revenue YoY
-15.4%
118.2%
Net Profit YoY
-243.5%
EPS (diluted)
$0.30
$-2.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
PED
PED
Q4 25
$39.9M
$23.1M
Q3 25
$39.5M
$7.0M
Q2 25
$38.6M
$7.0M
Q1 25
$41.6M
$8.7M
Q4 24
$47.1M
$10.6M
Q3 24
$47.6M
$9.1M
Q2 24
$45.0M
$11.8M
Q1 24
$45.4M
$8.1M
Net Profit
HHS
HHS
PED
PED
Q4 25
$2.2M
$-8.5M
Q3 25
$-2.3M
$-325.0K
Q2 25
$-335.0K
$-1.7M
Q1 25
$-392.0K
$140.0K
Q4 24
$5.9M
Q3 24
$142.0K
$2.9M
Q2 24
$-27.8M
$2.7M
Q1 24
$-171.0K
$773.0K
Operating Margin
HHS
HHS
PED
PED
Q4 25
-0.3%
-21.3%
Q3 25
1.3%
-12.0%
Q2 25
0.1%
-32.2%
Q1 25
-0.1%
1.7%
Q4 24
-3.3%
-12.9%
Q3 24
4.0%
31.3%
Q2 24
3.0%
22.3%
Q1 24
0.8%
7.6%
Net Margin
HHS
HHS
PED
PED
Q4 25
5.5%
-36.8%
Q3 25
-5.8%
-4.7%
Q2 25
-0.9%
-24.0%
Q1 25
-0.9%
1.6%
Q4 24
56.0%
Q3 24
0.3%
32.2%
Q2 24
-61.8%
22.7%
Q1 24
-0.4%
9.5%
EPS (diluted)
HHS
HHS
PED
PED
Q4 25
$0.30
$-2.23
Q3 25
$-0.31
$0.00
Q2 25
$-0.05
$-0.02
Q1 25
$-0.05
$0.00
Q4 24
$-0.31
$2.69
Q3 24
$0.02
$0.03
Q2 24
$-3.84
$0.03
Q1 24
$-0.02
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
PED
PED
Cash + ST InvestmentsLiquidity on hand
$5.6M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.5M
$207.4M
Total Assets
$91.8M
$375.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
PED
PED
Q4 25
$5.6M
$3.2M
Q3 25
$6.5M
$10.9M
Q2 25
$4.8M
$8.5M
Q1 25
$9.0M
$10.4M
Q4 24
$9.8M
$4.0M
Q3 24
$5.9M
$4.6M
Q2 24
$11.0M
$6.1M
Q1 24
$11.5M
$13.3M
Stockholders' Equity
HHS
HHS
PED
PED
Q4 25
$20.5M
$207.4M
Q3 25
$19.9M
$115.4M
Q2 25
$22.2M
$115.2M
Q1 25
$21.4M
$116.2M
Q4 24
$21.7M
$115.6M
Q3 24
$21.0M
$106.5M
Q2 24
$20.6M
$103.2M
Q1 24
$20.0M
$100.0M
Total Assets
HHS
HHS
PED
PED
Q4 25
$91.8M
$375.9M
Q3 25
$92.7M
$135.9M
Q2 25
$95.0M
$136.8M
Q1 25
$100.6M
$145.6M
Q4 24
$101.8M
$128.3M
Q3 24
$108.1M
$114.3M
Q2 24
$109.7M
$111.0M
Q1 24
$113.4M
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
PED
PED
Operating Cash FlowLast quarter
$737.0K
$-2.1M
Free Cash FlowOCF − Capex
$-686.0K
FCF MarginFCF / Revenue
-1.7%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
PED
PED
Q4 25
$737.0K
$-2.1M
Q3 25
$3.2M
$7.4M
Q2 25
$-4.8M
$-420.0K
Q1 25
$-818.0K
$5.9M
Q4 24
$4.0M
$4.2M
Q3 24
$-2.9M
$8.3M
Q2 24
$1.6M
$4.6M
Q1 24
$-5.7M
$-4.3M
Free Cash Flow
HHS
HHS
PED
PED
Q4 25
$-686.0K
Q3 25
$2.2M
Q2 25
$-5.1M
Q1 25
$-923.0K
Q4 24
$3.4M
Q3 24
$-4.9M
Q2 24
$926.0K
Q1 24
$-6.2M
FCF Margin
HHS
HHS
PED
PED
Q4 25
-1.7%
Q3 25
5.5%
Q2 25
-13.1%
Q1 25
-2.2%
Q4 24
7.3%
Q3 24
-10.2%
Q2 24
2.1%
Q1 24
-13.7%
Capex Intensity
HHS
HHS
PED
PED
Q4 25
3.6%
Q3 25
2.5%
Q2 25
0.6%
Q1 25
0.3%
Q4 24
1.3%
Q3 24
4.0%
Q2 24
1.5%
Q1 24
1.2%
Cash Conversion
HHS
HHS
PED
PED
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
42.34×
Q4 24
0.71×
Q3 24
-20.76×
2.83×
Q2 24
1.71×
Q1 24
-5.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

PED
PED

Segment breakdown not available.

Related Comparisons